245 related articles for article (PubMed ID: 7477961)
1. Neonatal 6-hydroxydopamine lesions lead to opposing changes in the levels of dopamine receptors and their messenger RNAs.
Frohna PA; Neal-Beliveau BS; Joyce JN
Neuroscience; 1995 Sep; 68(2):505-18. PubMed ID: 7477961
[TBL] [Abstract][Full Text] [Related]
2. Changes of D1 and D2 receptors in adult rat neostriatum after neonatal dopamine denervation: quantitative data from ligand binding, in situ hybridization and iontophoresis.
Radja F; el Mansari M; Soghomonian JJ; Dewar KM; Ferron A; Reader TA; Descarries L
Neuroscience; 1993 Dec; 57(3):635-48. PubMed ID: 7906013
[TBL] [Abstract][Full Text] [Related]
3. There is a limited critical period for dopamine's effects on D1 receptor expression in the developing rat neostriatum.
Thomas WS; Neal-Beliveau BS; Joyce JN
Brain Res Dev Brain Res; 1998 Nov; 111(1):99-106. PubMed ID: 9804909
[TBL] [Abstract][Full Text] [Related]
4. Ontogeny of D1A and D2 dopamine receptor subtypes in rat brain using in situ hybridization and receptor binding.
Schambra UB; Duncan GE; Breese GR; Fornaretto MG; Caron MG; Fremeau RT
Neuroscience; 1994 Sep; 62(1):65-85. PubMed ID: 7816213
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D1 receptor modulation of glutamate receptor messenger RNA levels in the neocortex and neostriatum of unilaterally 6-hydroxydopamine-lesioned rats.
Rodríguez-Puertas R; Herrera-Marschitz M; Koistinaho J; Hökfelt T
Neuroscience; 1999 Mar; 89(3):781-97. PubMed ID: 10199613
[TBL] [Abstract][Full Text] [Related]
6. Dopamine receptors status after unilateral nigral 6-OHDA lesion. Autoradiographic and in situ hybridization study in the rat brain.
Fornaretto MG; Caccia C; Caron MG; Fariello RG
Mol Chem Neuropathol; 1993; 19(1-2):147-62. PubMed ID: 8363701
[TBL] [Abstract][Full Text] [Related]
7. Timing: A critical determinant of the functional consequences of neonatal 6-OHDA lesions.
Neal-Beliveau BS; Joyce JN
Neurotoxicol Teratol; 1999; 21(2):129-40. PubMed ID: 10192273
[TBL] [Abstract][Full Text] [Related]
8. Development of striatal dopaminergic function. I. Pre- and postnatal development of mRNAs and binding sites for striatal D1 (D1a) and D2 (D2a) receptors.
Jung AB; Bennett JP
Brain Res Dev Brain Res; 1996 Jul; 94(2):109-20. PubMed ID: 8836569
[TBL] [Abstract][Full Text] [Related]
9. D1 dopamine receptor binding and mRNA levels are not altered after neonatal 6-hydroxydopamine treatment: evidence against dopamine-mediated induction of D1 dopamine receptors during postnatal development.
Duncan GE; Breese GR; Criswell HE; Johnson KB; Schambra UB; Mueller RA; Caron MG; Fremeau RT
J Neurochem; 1993 Oct; 61(4):1255-62. PubMed ID: 8376983
[TBL] [Abstract][Full Text] [Related]
10. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
[TBL] [Abstract][Full Text] [Related]
11. Neonatal dopamine depletion reveals a synergistic mechanism of mRNA regulation that is mediated by dopamine(D1) and serotonin(2) receptors and is targeted to tachykinin neurons of the dorsomedial striatum.
Campbell BM; Gresch PJ; Walker PD
Neuroscience; 2001; 105(3):671-80. PubMed ID: 11516832
[TBL] [Abstract][Full Text] [Related]
12. Temporal changes in the messenger RNA levels of cellular immediate early genes and neurotransmitter/receptor genes in the rat neostriatum and substantia nigra after acute treatment with eticlopride, a dopamine D2 receptor antagonist.
Sirinathsinghji DJ; Schuligoi R; Heavens RP; Dixon A; Iversen SD; Hill RG
Neuroscience; 1994 Sep; 62(2):407-23. PubMed ID: 7830888
[TBL] [Abstract][Full Text] [Related]
13. The neonatal lesion of the meso-telencephalic dopaminergic pathway increases intrastriatal D2 receptor levels and synthesis and this effect is reversed by neonatal dopaminergic rich-graft.
Mennicken F; Savasta M; Chritin M; Feuerstein C; Le Moal M; Herman JP; Abrous DN
Brain Res Mol Brain Res; 1995 Feb; 28(2):211-21. PubMed ID: 7723620
[TBL] [Abstract][Full Text] [Related]
14. Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra.
Newman-Tancredi A; Cussac D; Brocco M; Rivet JM; Chaput C; Touzard M; Pasteau V; Millan MJ
Brain Res; 2001 Nov; 920(1-2):41-54. PubMed ID: 11716810
[TBL] [Abstract][Full Text] [Related]
15. Distribution of messenger RNAs for D1 dopamine receptors and DARPP-32 in striatum and cerebral cortex of the cynomolgus monkey: relationship to D1 dopamine receptors.
Brené S; Hall H; Lindefors N; Karlsson P; Halldin C; Sedvall G
Neuroscience; 1995 Jul; 67(1):37-48. PubMed ID: 7477907
[TBL] [Abstract][Full Text] [Related]
16. Distribution and postnatal ontogeny of adenosine A2A receptors in rat brain: comparison with dopamine receptors.
Johansson B; Georgiev V; Fredholm BB
Neuroscience; 1997 Oct; 80(4):1187-207. PubMed ID: 9284070
[TBL] [Abstract][Full Text] [Related]
17. The temporal evolution of striatal dopamine receptor binding and mRNA expression following hypoxia-ischemia in the neonatal rat.
Filloux FM; Adair J; Narang N
Brain Res Dev Brain Res; 1996 Jun; 94(1):81-91. PubMed ID: 8816280
[TBL] [Abstract][Full Text] [Related]
18. Chronic blockade of muscarinic cholinergic receptors by systemic trihexyphenidyl (Artane) administration modulates but does not mediate the dopaminergic regulation of striatal prepropeptide messenger RNA expression.
Mavridis M; Rogard M; Besson MJ
Neuroscience; 1995 May; 66(1):37-53. PubMed ID: 7637873
[TBL] [Abstract][Full Text] [Related]
19. Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine.
Morissette M; Goulet M; Calon F; Falardeau P; Blanchet PJ; Bédard PJ; Di Paolo T
Mol Pharmacol; 1996 Nov; 50(5):1073-9. PubMed ID: 8913337
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide messenger RNA expression in the 6-hydroxydopamine-lesioned rat striatum reinnervated by fetal dopaminergic transplants: differential effects of the grafts on preproenkephalin, preprotachykinin and prodynorphin messenger RNA levels.
Cenci MA; Campbell K; Björklund A
Neuroscience; 1993 Nov; 57(2):275-96. PubMed ID: 8115038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
